Can oncologists predict survival for patients with progressive disease after standard chemotherapies?

Por Taniyama, T.K., Hashimoto, K., Katsumata, N., Hirakawa, A., Yonemori, K., Yunokawa, M., Shimizu, C., Tamura, K., Ando, M., Fujiwara, Y.
Publicado em 2014

Irinotecan plus carboplatin for patients with carcinoma of unknown primary site

Por Yonemori, K, Ando, M, Yunokawa, M, Hirata, T, Kouno, T, Shimizu, C, Tamura, K, Katsumata, N, Hirakawa, A, Matsumoto, K, Yamanaka, Y, Arioka, H, Fujiwara, Y
Publicado em 2009

Clinical and microarray analysis of breast cancers of all subtypes from two prospective preoperative chemotherapy studies

Por Okuma, H S, Koizumi, F, Hirakawa, A, Nakatochi, M, Komori, O, Hashimoto, J, Kodaira, M, Yunokawa, M, Yamamoto, H, Yonemori, K, Shimizu, C, Fujiwara, Y, Tamura, K
Publicado no Br J Cancer (2016)